£114.75

Springer Sphingolipids and Metabolic Disease: 721 (Advances in Experimental Medicine and Biology, 721)

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£115 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£116.43 £114.58 £114.99 £115.39 £115.79 £116.19 £116.60 08 March 2026 30 March 2026 22 April 2026 14 May 2026 06 June 2026

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price
Current Price
73 days · current 18 days 0 18 37 55 73 £115 £116 Days at Price

Price Analysis

Most common price: £115 (73 days, 80.2%)

Price range: £115 - £116

Price levels: 2 different prices over 91 days

Description

Current thinking holds that obesity derives primarily from overnutrition (though compelling arguments for other mechanisms, like endocrine disruption by environmental pollutants, also gain support from the literature). In animals, overnutrition is initially handled by adipose tissue expansion; however, exhaustion of this route of lipid sequestering results in oversupply of lipid to other tissues including skeletal muscle, heart, liver, and others. Failure of these tissues to clear excess lipids through either metabolism or sequestration into putatively inert triacylglycerols results in perturbation of bioactive lipid metabolism in cells. In particular, aberrant generation of bioactive sphingolipids is implicated in a multitude of pathological outcomes of metabolic disease including insulin resistance, inflammation, cardiomyopathy, and others. This volume addresses not only the fundamentals of sphingolipid metabolism and analysis, but also the roles of sphingolipids in these disease processes.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
05 August 2011
Listed Since
20 May 2011

Barcode

No barcode data available

Similar Products You Might Like

Lipid-mediated Protein Signaling: 991 (Advances in Experimental Medicine and Biology, 991)
83% match

Lipid-mediated Protein Signaling: 991 (Advances in Experimental Medicine and Biology, 991)

Springer

£107.98 01 Jun 2026
The Metabolic Syndrome: Pharmacology and Clinical Aspects
82% match

The Metabolic Syndrome: Pharmacology and Clinical Aspects

Springer

£128.31 27 May 2026
Controversies in Obesity
82% match

Controversies in Obesity

Springer

£73.10 27 May 2026
Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)
82% match

Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)

Springer

£108.92 11 May 2026
Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome
81% match

Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome

Springer

£107.98 31 May 2026
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development
81% match

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

Springer

£111.22 24 May 2026
Overweight and the Metabolic Syndrome:: From Bench to Bedside: 26 (Endocrine Updates, 26)
81% match

Overweight and the Metabolic Syndrome:: From Bench to Bedside: 26 (Endocrine Updates, 26)

Springer

£107.98 26 May 2026
Metabolic Control: 233 (Handbook of Experimental Pharmacology, 233)
81% match

Metabolic Control: 233 (Handbook of Experimental Pharmacology, 233)

Springer

£120.00 05 Jun 2026
Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)
81% match

Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)

Springer

£109.57 01 Jun 2026
Chronobiology and Obesity
81% match

Chronobiology and Obesity

Springer

£106.68 26 May 2026
Obesity, Inflammation and Cancer: 7 (Energy Balance and Cancer, 7)
80% match

Obesity, Inflammation and Cancer: 7 (Energy Balance and Cancer, 7)

Springer

£107.98 28 May 2026
The Mechanobiology of Obesity and Related Diseases: 16 (Studies in Mechanobiology, Tissue Engineering and Biomaterials, 16)
80% match

The Mechanobiology of Obesity and Related Diseases: 16 (Studies in Mechanobiology, Tissue Engineering and Biomaterials, 16)

Springer

£76.38 03 Jun 2026
Multidisciplinary Approach to Obesity: From Assessment to Treatment
80% match

Multidisciplinary Approach to Obesity: From Assessment to Treatment

Springer

£39.33 21 May 2026
Animal Models: Disorders of Eating Behaviour and Body Composition
80% match

Animal Models: Disorders of Eating Behaviour and Body Composition

Springer

£113.76 06 Jun 2026
Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function
80% match

Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function

Springer

£65.57 20 May 2026
Hepatic De Novo Lipogenesis and Regulation of Metabolism
80% match

Hepatic De Novo Lipogenesis and Regulation of Metabolism

Springer

£107.98 05 Jun 2026
Early Nutrition Programming and Health Outcomes in Later Life: Obesity and beyond: 646 (Advances in Experimental Medicine and Biology, 646)
80% match

Early Nutrition Programming and Health Outcomes in Later Life: Obesity and beyond: 646 (Advances in Experimental Medicine and Biology, 646)

Springer

£118.47 01 Jun 2026
The Clinician’s Guide to the Treatment of Obesity (Endocrine Updates)
80% match

The Clinician’s Guide to the Treatment of Obesity (Endocrine Updates)

Springer

£80.64 21 May 2026
Adipose Tissue: Endocrine Functions, Health Implications, and Future Perspectives (Contemporary Endocrinology)
80% match

Adipose Tissue: Endocrine Functions, Health Implications, and Future Perspectives (Contemporary Endocrinology)

Springer

£73.40 24 May 2026
Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)
79% match

Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)

Springer

£76.13 31 May 2026
Pediatric Overweight and Obesity: Comorbidities, Trajectories, Prevention and Treatments
79% match

Pediatric Overweight and Obesity: Comorbidities, Trajectories, Prevention and Treatments

Springer

£73.10 31 May 2026
Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)
79% match

Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)

Springer

£76.38 25 May 2026
Cardiac Energy Metabolism in Health and Disease: 11 (Advances in Biochemistry in Health and Disease, 11)
79% match

Cardiac Energy Metabolism in Health and Disease: 11 (Advances in Biochemistry in Health and Disease, 11)

Springer

£76.06 26 May 2026
Phosphatidylcholine: Biochemical and Clinical Aspects of Essential Phospholipids
79% match

Phosphatidylcholine: Biochemical and Clinical Aspects of Essential Phospholipids

Springer

£108.83 20 May 2026